Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
Journal
Frontiers in Oncology
Journal Volume
10
Pages
590356
Date Issued
2021
Author(s)
SDGs
Publisher
Frontiers Media S.A.
Type
journal article
